Last reviewed · How we verify
Propofol sedation
At a glance
| Generic name | Propofol sedation |
|---|---|
| Also known as | ATC code: N01AX10, CAS no: 2078-54-8 |
| Sponsor | University of California, Los Angeles |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives (NA)
- Actualities in Procedural Sedation: Remimazolam (PHASE4)
- Target-controlled Infusion With Propofol in the Emergency Department : a Prospective Study on 45 Adult Patients (PHASE4)
- Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2) (PHASE3)
- Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1) (PHASE3)
- THRIVE in Sedated Gastrointestinal Endoscopy
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol sedation CI brief — competitive landscape report
- Propofol sedation updates RSS · CI watch RSS
- University of California, Los Angeles portfolio CI